Merlin Nexus

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2016	Zymeworks	$62.0M Series A	BDC Venture Capital, Daniel Hétu	Amplitude VC, MPM Capital, Relay Ventures, Venrock, Anthony Lacavera, Brace Pharma Capital, Celgene, CTI Life Sciences Fund, Eli Lilly and Company, Northleaf Capital Partners, Perceptive Advisors, Teralys Capital

Total Raised

N/A

Valuation

N/A